| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
422,654 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
166,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$81,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
732 |
5,434 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-07-27 |
4 |
D |
$20.60 |
$3,172 |
D/D |
(154) |
4,702 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2017-07-27 |
4 |
D |
$20.60 |
$2,431 |
D/D |
(118) |
22,971 |
|
- |
|
| Abt John |
Vice President of Quality |
• – – |
2017-07-27 |
4 |
D |
$20.60 |
$2,390 |
D/D |
(116) |
8,519 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-07-27 |
4 |
D |
$20.60 |
$8,796 |
D/D |
(427) |
686,423 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-07-27 |
4 |
D |
$20.60 |
$2,699 |
D/D |
(131) |
18,601 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2017-07-27 |
4 |
D |
$20.60 |
$3,770 |
D/D |
(183) |
39,232 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-07-23 |
4 |
D |
$21.50 |
$1,118 |
D/D |
(52) |
4,856 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2017-07-23 |
4 |
D |
$21.50 |
$18,275 |
D/D |
(850) |
39,415 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-07-23 |
4 |
D |
$21.50 |
$17,630 |
D/D |
(820) |
18,732 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-07-23 |
4 |
D |
$21.50 |
$37,002 |
D/D |
(1,721) |
686,850 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-07-22 |
4 |
D |
$21.50 |
$3,311 |
D/D |
(154) |
4,908 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2017-07-22 |
4 |
D |
$21.50 |
$9,847 |
D/D |
(458) |
40,265 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-07-22 |
4 |
D |
$21.50 |
$6,945 |
D/D |
(323) |
19,552 |
|
- |
|
| Bedrosian Arthur P |
CEO |
• • – |
2017-07-22 |
4 |
D |
$21.50 |
$16,985 |
D/D |
(790) |
688,571 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2017-07-22 |
4 |
D |
$21.50 |
$8,235 |
D/D |
(383) |
23,089 |
|
- |
|
| Abt John |
Vice President of Quality |
• – – |
2017-07-22 |
4 |
D |
$21.50 |
$2,129 |
D/D |
(99) |
8,635 |
|
- |
|
| Maher James M. |
Director |
– • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,977 |
27,297 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,977 |
31,775 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,977 |
14,082 |
|
- |
|
| Drabik David A |
Director |
– • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,977 |
31,552 |
|
- |
|
| Farber Jeffrey |
Director |
– • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,977 |
2,445,803 |
|
- |
|
| Israel Samuel H |
Chief Legal OfficerOfficer |
• – – |
2017-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,223 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2017-06-30 |
4 |
A |
$17.34 |
$5,167 |
D/D |
298 |
5,062 |
|
- |
|
| Smith Kevin |
VP of Sales and Marketing |
• – – |
2017-06-30 |
4 |
A |
$17.34 |
$9,953 |
D/D |
574 |
19,875 |
|
- |
|
762 Records found
|
|
Page 12 of 31 |
|
|
